Results 121 to 130 of about 1,541,059 (150)
External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs [PDF]
Journal of Hepatology, 2021 Nabiel Mikhail +2 more
exaly +3 more sources
Reply to: “External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs” [PDF]
Journal of Hepatology, 2021 Jinlin Hou, Xueru Yin, Rong Fan
exaly +3 more sources
Journal of Clinical and Experimental HepatologyWe aimed to perform a meta-analysis with the intention of evaluating the reliability and test accuracy of the aMAP risk score in the identification of HCC.A systematic search was performed in PubMed, Scopus, Cochrane, Embase, and Web of Science databases from inception to September 2023, to identify studies measuring the aMAP score in patients for the ...
Anas Elgenidy +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hpb
The aMAP score is a proposed model to predict the development of hepatocellular carcinoma (HCC) among high-risk patients with chronic hepatitis. The role of the aMAP score to predict long-term survival among patients following resection of HCC has not been determined.Patients undergoing resection for HCC between 2000 and 2020 were identified using a ...
Vincent Lam +2 more
exaly +3 more sources
The aMAP score is a proposed model to predict the development of hepatocellular carcinoma (HCC) among high-risk patients with chronic hepatitis. The role of the aMAP score to predict long-term survival among patients following resection of HCC has not been determined.Patients undergoing resection for HCC between 2000 and 2020 were identified using a ...
Vincent Lam +2 more
exaly +3 more sources
Zhonghua nei ke za zhi, 2023
Objective: To explore the value of the aMAP risk score (age, male, albumin-bilirubin, and platelets) to predict early recurrence within one year after microwave ablation in patients with small hepatocellular carcinoma. Methods: This was a retrospective study that enrolled 142 patients diagnosed with hepatocellular carcinoma who were treated with ...
S Y, Dong +6 more
openaire +1 more source
Objective: To explore the value of the aMAP risk score (age, male, albumin-bilirubin, and platelets) to predict early recurrence within one year after microwave ablation in patients with small hepatocellular carcinoma. Methods: This was a retrospective study that enrolled 142 patients diagnosed with hepatocellular carcinoma who were treated with ...
S Y, Dong +6 more
openaire +1 more source
Hepatology Research
ABSTRACT Backgrounds This study aimed to investigate the incidence and potential risk factors for hepatic encephalopathy (HE) recurrence following the initiation of rifaximin therapy in patients with liver cirrhosis. Methods
Hiroki Tojima +2 more
exaly +3 more sources
ABSTRACT Backgrounds This study aimed to investigate the incidence and potential risk factors for hepatic encephalopathy (HE) recurrence following the initiation of rifaximin therapy in patients with liver cirrhosis. Methods
Hiroki Tojima +2 more
exaly +3 more sources